In a deal worth up to $1.15 billion, GSK is acquiring precision medicine biotech IDRx and its phase 3-ready gastrointestinal ...

Ramakrishnan used the example of GSK’s work against chronic hepatitis B, with new data capabilities helping ... and whether you’re building talent and capabilities. “This means that we ...

A high-profile team of architects, landscape designers, and consultants has been appointed to progress a masterplan for the redevelopment of the former GSK headquarters at 980 Great West Road, ...

We recently compiled a list of the 12 Cheapest Stocks with Biggest Upside Potential. In this article, we are going to take a ...

In oncology, GSK has been building a portfolio of “antibody drug conjugates”, a new type of chemotherapy that aims to kill cancerous cells while sparing healthy ones. Late last year ...

Taryn Paehr says that even in her earliest days as a student intern with GlaxoSmithKline Inc. (GSK), she realized the biopharmaceutical company offered the sort of workplace where she could grow ...

In addition to established platform technologies, GSK is building new platforms such as the Multiple Antigen-Presenting System (MAPS) and mRNA, key to addressing the most complex diseases.

Building this trust among employees involves ... is aiming to “do the right thing” for wider society. With the new goals, GSK aims to have a net zero impact on climate and a net positive ...